Form4insider filings, from the source

SEC Form 4 · accession 0000899243-16-021967

Baxalta Inc · BXLT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Dagmar Rosa-Bjorkeson
Officer — EVP and President, Biosimilars
Period of report
Jun 3, 2016
Accepted (ET)
Jun 7, 2016 · 4:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001620546

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common Stock, par value $0.01 per shareF1,F3Jun 3, 2016D71,293—D0D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy)F4$33.63Jun 3, 2016D86,669D—Dec 1, 2024Common Stock, par value $0.01 per share86,6690D
Stock Option (Right to Buy)F5$32.04Jun 3, 2016D54,553D—Mar 3, 2025Common Stock, par value $0.01 per share54,5530D

Explanation of responses